Roughly 1 in 12 cancer survivors used cannabis, and the pattern of use varied based on clinico-demographic factors and concurrent substance use such as tobacco or alcohol. Cannabis use among cancer survivors who resided in states that legalized cannabis was higher.
Marijuana Use and Lower Obesity Rates: A Correlation, Not a Cure
For obese individuals, prevalence of current marijuana use is 35% lower than for non-obese individuals on average. The adjusted odds of current or daily marijuana use are significantly lower among obese versus non-obese adults (0.68 and 0.69, respectively).
About 1 in 12 Cancer Survivors Used Cannabis, National Survey Finds
Roughly 1 in 12 cancer survivors used cannabis. The pattern of use varied based on clinicodemographic factors and concurrent substance use such as tobacco or alcohol. Cannabis use among cancer survivors who resided in states that legalized cannabis was higher.
Marijuana Users Have Lower Obesity Rates, But Does the Drug Cause This?
For obese individuals, prevalence of current marijuana use is 35% lower than for non-obese individuals on average. Lower prevalence of marijuana use in obese individuals is consistently observed across the levels of certain demographic variables, employment status, tobacco smoking history, marijuana legalization status, and certain medical conditions.
Classic psychedelic and cannabis use among U.S. cancer survivors aged ≥ 50 years: nationally representative estimates by cancer type/site.
To examine the prevalence of lifetime (“ever”) cannabis and classic psychedelic use, and their co-use among U.S. adults aged ≥ 50 years with versus without a…
Research study on Maltese cannabis users (Still open for participants) : r/malta – Reddit
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Public HealthInternational PolicyReal-World EvidenceEpidemiologyRegulation Why This Matters Malta legalized adult cannabis use in...
Association of cannabis use and lung cancer: a retrospective cohort study
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Pulmonary HealthCancer RiskSafetyEpidemiologyHarm Reduction Why This Matters This retrospective cohort study adds to...
Recent research indicates that daily cannabis use has surpassed daily alcohol consumption …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Substance UseEpidemiologyHarm ReductionScreeningPublic Health Why This MattersThis epidemiological shift represents a fundamental change in...
Classic psychedelic and cannabis use among U.S. cancer survivors aged ≥ 50 years: nationally representative estimates by cancer type/site.
To examine the prevalence of lifetime (“ever”) cannabis and classic psychedelic use, and their co-use among U.S. adults aged ≥ 50 years with versus without a…
Trends in Cannabis and Tobacco Use by Racial and Ethnic Groups among U.S. Youth: 1991-2021
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic YouthEpidemiologyPreventionHealth DisparitiesSubstance Use Why This MattersUnderstanding demographic patterns in youth cannabis use is essential...